Literature DB >> 14971644

Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells.

Ning Gao1, Liqin Shen, Zhuo Zhang, Stephen S Leonard, Hengjun He, Xue-Guang Zhang, Xianglin Shi, Bing-Hua Jiang.   

Abstract

Arsenite is widely distributed environmental toxicant in water, food and air. It is a known human carcinogen, which is strongly associated with human cancers originated from liver, nasal cavity, lung, skin, bladder, kidney, and prostate. In this study, we investigated whether arsenite induces expression of hypoxia-inducible factor 1 (HIF-1). HIF-1 is a heterodimeric basic helix-loop-helix transcription factor, composed of HIF-1alpha and HIF-1beta/ARNT subunits; and is involved in tumor growth and angiogenesis. Here we demonstrate that arsenite induces the expression of HIF-1alpha but not HIF-1beta subunit in DU145 human prostate carcinoma cells. Arsenite also increases the expression of VEGF through the induction of HIF-1. We also found that arsenite activates PI3K and Akt that are required for arsenite-induced expression of HIF-1alpha and VEGF. The induction of HIF-1 and VEGF by arsenite can not be inhibited by MAP kinase inhibitors. Arsenite causes production of reactive oxygen species (ROS). The major species of ROS required for the induction of HIF-1 and VEGF is H2O2. These data indicate that the arsenite-induced activation of PI3K/Akt signaling and the expression of HIF-1 and VEGF through the generation of ROS could be an important mechanism in the arsenite-induced carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971644     DOI: 10.1023/b:mcbi.0000007259.65742.16

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  71 in total

1.  Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite.

Authors:  Ja-Young Kim; Jung-A Choi; Tae-Hwan Kim; Young-Do Yoo; Jong-Il Kim; Yong J Lee; Seong-Yul Yoo; Chul-Koo Cho; Yun-Sil Lee; Su-Jae Lee
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

2.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia.

Authors:  P J Lee; B H Jiang; B Y Chin; N V Iyer; J Alam; G L Semenza; A M Choi
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Authors:  L E Benjamin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 7.  Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review).

Authors:  E Minet; G Michel; J Remacle; C Michiels
Journal:  Int J Mol Med       Date:  2000-03       Impact factor: 4.101

Review 8.  Structural and functional analysis of hypoxia-inducible factor 1.

Authors:  G L Semenza; F Agani; G Booth; J Forsythe; N Iyer; B H Jiang; S Leung; R Roe; C Wiener; A Yu
Journal:  Kidney Int       Date:  1997-02       Impact factor: 10.612

9.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

10.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more
  39 in total

1.  Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation.

Authors:  Chih-Hsien Wu; Sheau-Chung Tang; Po-Hui Wang; Huei Lee; Jiunn-Liang Ko
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Ethanol enhances tumor angiogenesis in vitro induced by low-dose arsenic in colon cancer cells through hypoxia-inducible factor 1 alpha pathway.

Authors:  Lei Wang; Young-Ok Son; Songze Ding; Xin Wang; John Andrew Hitron; Amit Budhraja; Jeong-Chae Lee; Qinchen Lin; Pratheeshkumar Poyil; Zhuo Zhang; Jia Luo; Xianglin Shi
Journal:  Toxicol Sci       Date:  2012-08-07       Impact factor: 4.849

3.  Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.

Authors:  Yi Jing; Ling-Zhi Liu; Yue Jiang; Yingxue Zhu; Nancy Lan Guo; John Barnett; Yon Rojanasakul; Faton Agani; Bing-Hua Jiang
Journal:  Toxicol Sci       Date:  2011-10-09       Impact factor: 4.849

4.  Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.

Authors:  Ravinder Tammali; Ashish Saxena; Satish K Srivastava; Kota V Ramana
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

5.  Nickel induces transcriptional down-regulation of DNA repair pathways in tumorigenic and non-tumorigenic lung cells.

Authors:  Susan E Scanlon; Christine D Scanlon; Denise C Hegan; Parker L Sulkowski; Peter M Glazer
Journal:  Carcinogenesis       Date:  2017-06-01       Impact factor: 4.944

6.  ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.

Authors:  Mahandranauth A Chetram; Ayesha S Don-Salu-Hewage; Cimona V Hinton
Journal:  Biochem Biophys Res Commun       Date:  2011-05-24       Impact factor: 3.575

7.  Role of reactive oxygen species in arsenic-induced transformation of human lung bronchial epithelial (BEAS-2B) cells.

Authors:  Zhuo Zhang; Poyil Pratheeshkumar; Amit Budhraja; Young-Ok Son; Donghern Kim; Xianglin Shi
Journal:  Biochem Biophys Res Commun       Date:  2014-12-10       Impact factor: 3.575

8.  Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo.

Authors:  Sung Keun Jung; Ki Won Lee; Sanguine Byun; Eun Jung Lee; Jong-Eun Kim; Ann M Bode; Zigang Dong; Hyong Joo Lee
Journal:  Carcinogenesis       Date:  2009-12-11       Impact factor: 4.944

Review 9.  Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Drug Resist Updat       Date:  2008-04-28       Impact factor: 18.500

Review 10.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.

Authors:  Masuko Ushio-Fukai; Yoshimasa Nakamura
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.